RHUMBLINE ADVISERS - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 48 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q1 2019$44,000
-18.5%
22,972
-1.7%
0.00%–
Q4 2018$54,000
-50.0%
23,372
+47.2%
0.00%–
Q3 2018$108,000
-72.9%
15,882
-5.9%
0.00%
-100.0%
Q2 2018$398,000–16,869–0.00%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q3 2018.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders